GENETIC AND BIOCHEMICAL BASES FOR S MUTANS VIRULENCE
GENETIC AND BIOCHEMICAL BASES FOR S MUTANS VIRULENCE
批准号:
2458583
负责人:
ROY CURTISS III
金额:
$23.94万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1983
资助国家:
美国
项目状态:
已结题
起止时间:
1983-08-01 至 1999-07-31
关键词:
Escherichia coli k12 Streptococcus mutans antibacterial antibody bacterial DNA bacterial antigens bacterial genetics carbohydrate metabolism carbohydrate transport cell membrane cell wall dental plaque enzyme structure genetic manipulation genetic recombination genetic regulation glycogen host organism interaction laboratory rabbit messenger RNA microorganism immunology microorganism metabolism molecular biology molecular cloning nucleic acid sequence oral bacteria oxidoreductase phosphotransferases protein transport pyrimidines recombinant DNA transferase virulence
中文摘要
将采用遗传学、生物化学和免疫学方法
研究致病力的遗传和生化基础
变形链球菌S. mutans、S. sobrinus,S.
cricetus和S.致龋细菌的啮齿动物。 S. 变异DNA
已经并将继续被克隆到适当的
大肠杆菌K-12宿主。 克隆指定信息
被认为是重要的,有助于能力的S。变形
定殖和显示毒力的特性。 方法
将使用克隆的基因探针来定量mRNA
水平,以研究S. 变异基因
定殖和毒力属性,以及
中间碳水化合物代谢。 具体项目为
(一)继续进行分子遗传学分析,
spaA基因及其蛋白的生化特性
关于其功能和与其他表面相互作用
(二)继续进行大分子的分子遗传学分析,
dex基因,并表征葡聚糖酶及其内源性
抑制剂,以确定其在粘附和葡聚糖中作用
合成,(iii)继续修饰ASD基因编码
用于克隆的β-天冬氨酸半醛脱氢酶
并建立ASD监管机制
与嘧啶合成和细胞壁组装有关的基因,
(iv)克隆磷酸转移酶系统(PTS)的基因,
开展研究,建立糖运输机制,
利用,和(v)用于糖原合成的克隆基因,
并进行研究,以确定这些基因是如何
监管. 这些研究将有助于理解S.
变形杆菌保持代谢活性,包括酸代谢能力。
在菌斑环境中,
营养素的有效性和对其他生物活动的反应
菌斑微生物 这些研究还应提供
关于S.变形杆菌在暴露于
环境压力,特别是那些干扰细胞的压力,
细胞壁或细胞膜的合成或功能。 这项研究将
按照NIH重组指南进行
DNA研究
英文摘要
Genetic, biochemical and immunological approaches will be used
to investigate the genetic and biochemical bases for the virulence
of the Streptococcus mutans group S. mutans, S. sobrinus, S.
cricetus, and S. rattus of cariogenic bacteria. S. mutans DNA
has been and will continue to be cloned into appropriate
Escherichia coli K-12 hosts. Clones specifying information
thought to be important in contributing to the ability of S. mutans
to colonize and display virulence will be characterized. Methods
will be developed using cloned gene probes to quantify mRNA
levels to investigate regulation of S. mutans genes for
colonization and virulence attributes and for enzymes of
intermediary carbohydrate metabolism. The specific projects to
be pursued are to: (i) continue molecular genetic analysis of the
spaA gene and biochemical characterization of the SpaA protein
in relation to its functions and interactions with other surface
macromolecules, (ii) continue molecular genetic analysis of the
dex gene and to characterize dextranase and its endogenous
inhibitor to define their roles in adherence and in glucan
synthesis, (iii) continue modification of the asd gene encoding
beta-aspartate semialdehyde dehydrogenase for use in cloning
vectors and to establish mechanism(s) for regulation of the asd
gene in relation to pyrimidine synthesis and cell wall assembly,
(iv) clone genes for the phosphotransferase system (PTS) and
conduct studies to establish mechanisms for sugar transport and
utilization, and (v) clone genes for glycogen synthesis and
breakdown and conduct studies to determine how these genes are
regulated. These studies will contribute to understanding how S.
mutans maintains metabolic activity, including ability for acid
production, in the plaque environment with variation in the
availability of nutrients and in response to activities of other
plaque microorganisms. These studies should also provide
information on how S. mutans protects itself when exposed to
environmental stresses, especially those that interfere with cell
wall or cell membrane synthesis or function. The research will be
done in conformance with the NIH guidelines for recombinant
DNA research.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Overproduction of a dextranase inhibitor by Streptococcus sobrinus mutants.
远缘链球菌突变体过量产生葡聚糖酶抑制剂。
DOI:
10.1128/jb.176.23.7206-7212.1994
发表时间:
1994
期刊:
Journal of bacteriology
影响因子:
3.2
作者:
[Wanda,SY, Camilli,A, Murchison,HM, Curtiss3rd,R]
通讯作者:
Curtiss3rd,R
Purification, characterization, and specificity of dextranase inhibitor (Dei) expressed from Streptococcus sobrinus UAB108 gene cloned in Escherichia coli.
大肠杆菌中克隆的远缘链球菌 UAB108 基因表达的葡聚糖酶抑制剂 (Dei) 的纯化、表征和特异性。
DOI:
10.1128/jb.177.7.1703-1711.1995
发表时间:
1995
期刊:
Journal of bacteriology
影响因子:
3.2
作者:
[Sun,JW, Wanda,SY, Curtiss3rd,R]
通讯作者:
Curtiss3rd,R
Purification and characterization of Streptococcus sobrinus dextranase produced in recombinant Escherichia coli and sequence analysis of the dextranase gene.
重组大肠杆菌中产生的远缘链球菌葡聚糖酶的纯化和表征以及葡聚糖酶基因的序列分析。
DOI:
10.1128/jb.176.13.3839-3850.1994
发表时间:
1994
期刊:
Journal of bacteriology
影响因子:
3.2
作者:
[Wanda,SY, Curtiss3rd,R]
通讯作者:
Curtiss3rd,R
Cross-reactivity between the immunodominant determinant of the antigen I component of Streptococcus sobrinus SpaA protein and surface antigens from other members of the Streptococcus mutans group.
远缘链球菌 SpaA 蛋白的抗原 I 成分的免疫显性决定簇与来自变形链球菌群其他成员的表面抗原之间的交叉反应性。
DOI:
10.1128/iai.58.7.2276-2282.1990
发表时间:
1990
期刊:
Infection and immunity
影响因子:
3.1
作者:
[Goldschmidt,RM, Curtiss3rd,R]
通讯作者:
Curtiss3rd,R
Cloning and DNA sequencing of the dextranase inhibitor gene (dei) from Streptococcus sobrinus.
远缘链球菌葡聚糖酶抑制剂基因 (dei) 的克隆和 DNA 测序。
DOI:
10.1128/jb.176.23.7213-7222.1994
发表时间:
1994
期刊:
Journal of bacteriology
影响因子:
3.2
作者:
[Sun,JW, Wanda,SY, Camilli,A, Curtiss3rd,R]
通讯作者:
Curtiss3rd,R
Recombinant Attenuated Bacterial Vaccines Against Biodefense Agents
-
批准号:8259119
-
项目类别:
-
资助金额:$102.57万
-
财政年份:2011
-
负责人:ROY CURTISS III
-
依托单位:
Recombinant Attenuated Bacterial Vaccines Against Biodefense Agents
-
批准号:8653527
-
项目类别:
-
资助金额:$102.57万
-
财政年份:2011
-
负责人:ROY CURTISS III
-
依托单位:
Recombinant Attenuated Bacterial Vaccines Against Biodefense Agents
-
批准号:8075999
-
项目类别:
-
资助金额:$102.69万
-
财政年份:2011
-
负责人:ROY CURTISS III
-
依托单位:
Recombinant Attenuated Bacterial Vaccines Against Biodefense Agents
-
批准号:8463108
-
项目类别:
-
资助金额:$96.41万
-
财政年份:2011
-
负责人:ROY CURTISS III
-
依托单位:
Salmonella anti-influenza DNA & antigen delivery vaccine
-
批准号:6957620
-
项目类别:
-
资助金额:$27.46万
-
财政年份:2005
-
负责人:ROY CURTISS III
-
依托单位:
Salmonella anti-influenza DNA & antigen delivery vaccine
-
批准号:7112363
-
项目类别:
-
资助金额:$59.66万
-
财政年份:2005
-
负责人:ROY CURTISS III
-
依托单位:
Salmonella anti-influenza DNA & antigen delivery vaccine
-
批准号:7174221
-
项目类别:
-
资助金额:$71.2万
-
财政年份:2005
-
负责人:ROY CURTISS III
-
依托单位:
Salmonella anti-influenza DNA & antigen delivery vaccine
-
批准号:7342503
-
项目类别:
-
资助金额:$59.06万
-
财政年份:2005
-
负责人:ROY CURTISS III
-
依托单位:
Attenuated Live and Recombinant Yersinia Pestis Vaccines
-
批准号:7986572
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2004
-
负责人:ROY CURTISS III
-
依托单位:
Attenuated Live and Recombinant Yersinia Pestis Vaccines
-
批准号:8074038
-
项目类别:
-
资助金额:$37.74万
-
财政年份:2004
-
负责人:ROY CURTISS III
-
依托单位:
Attenuated Live and Recombinant Yersinia pestis Vaccines
-
批准号:7034308
-
项目类别:
-
资助金额:$54.0万
-
财政年份:2004
-
负责人:ROY CURTISS III
-
依托单位:
Attenuated Live and Recombinant Yersinia Pestis Vaccines
-
批准号:8658795
-
项目类别:
-
资助金额:$37.74万
-
财政年份:2004
-
负责人:ROY CURTISS III
-
依托单位:
Attenuated Live and Recombinant Yersinia Pestis Vaccines
-
批准号:8278020
-
项目类别:
-
资助金额:$37.74万
-
财政年份:2004
-
负责人:ROY CURTISS III
-
依托单位:
Attenuated Live and Recombinant Yersinia pestis Vaccines
-
批准号:6999740
-
项目类别:
-
资助金额:$58.98万
-
财政年份:2004
-
负责人:ROY CURTISS III
-
依托单位:
Attenuated Live and Recombinant Yersinia pestis Vaccines
-
批准号:7337293
-
项目类别:
-
资助金额:$59.42万
-
财政年份:2004
-
负责人:ROY CURTISS III
-
依托单位:
Attenuated Live and Recombinant Yersinia pestis Vaccines
-
批准号:6706631
-
项目类别:
-
资助金额:$58.5万
-
财政年份:2004
-
负责人:ROY CURTISS III
-
依托单位:
Attenuated Live and Recombinant Yersinia pestis Vaccines
-
批准号:7169880
-
项目类别:
-
资助金额:$58.9万
-
财政年份:2004
-
负责人:ROY CURTISS III
-
依托单位:
Attenuated Live and Recombinant Yersinia Pestis Vaccines
-
批准号:8470516
-
项目类别:
-
资助金额:$35.48万
-
财政年份:2004
-
负责人:ROY CURTISS III
-
依托单位:
Recombinant Attenuated Salmonella Vaccines for Humans
-
批准号:7034291
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2003
-
负责人:ROY CURTISS III
-
依托单位:
S. typhimiurium Vaccine Against Bacterial Enteropathogens
-
批准号:7284190
-
项目类别:
-
资助金额:$30.85万
-
财政年份:2003
-
负责人:ROY CURTISS III
-
依托单位:
海外基金